Professor Hisatomi Arima, MD PhD is a Head Professor of the Department of Preventive Medicine and Public Health, Fukuoka University, Fukuoka, Japan. Hisatomi holds specialist qualifications in Cardiology and Internal Medicine. He also worked as an epidemiologist for the Hisayama Study, a prospective cohort study of cardiovascular disease, at Kyushu University where completed his PhD degree in Medicine. Prior to taking up his position at Fukuoka University, he was appointed as a Special Contract Professor at the Center for Epidemiologic Research in Asia, the Shiga University of Medical Science for 2 years. Before then, he spent 2 years as a Senior Lecturer and 3 years as an Associate Professor at the George Institute for Global Health, University of Sydney, where he was involved in large-scale clinical trials of blood pressure lowering for acute and chronic phases of stroke including PROGRESS, INTERACT2 and ENCHANTED. Hisatomi has published on clinical and epidemiological aspects of hypertension, stroke and coronary heart disease, is an associate editor and a reviewer of scientific journals, and is a member of national and international societies of hypertension, stroke and cardiology.
Why are you excited about participating in APSC 2017?
Because of high incidence of stroke in Asia, it is very important to discuss strategies to prevent and treat stroke in the Asia Pacific region.